AU2002212630A1 - Corticosteroids adducts with natural polysaccharide polymers - Google Patents

Corticosteroids adducts with natural polysaccharide polymers

Info

Publication number
AU2002212630A1
AU2002212630A1 AU2002212630A AU1263002A AU2002212630A1 AU 2002212630 A1 AU2002212630 A1 AU 2002212630A1 AU 2002212630 A AU2002212630 A AU 2002212630A AU 1263002 A AU1263002 A AU 1263002A AU 2002212630 A1 AU2002212630 A1 AU 2002212630A1
Authority
AU
Australia
Prior art keywords
corticosteroids
adducts
natural polysaccharide
polysaccharide polymers
polymers
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002212630A
Inventor
Piergiorgio Anzaghi
Rosanna Stefli
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
PHARMA BIOTECH Ltd
Original Assignee
PHARMA BIOTECH Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by PHARMA BIOTECH Ltd filed Critical PHARMA BIOTECH Ltd
Publication of AU2002212630A1 publication Critical patent/AU2002212630A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • A61K31/665Phosphorus compounds having oxygen as a ring hetero atom, e.g. fosfomycin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/61Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule the organic macromolecular compound being a polysaccharide or a derivative thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
AU2002212630A 2000-11-17 2001-11-16 Corticosteroids adducts with natural polysaccharide polymers Abandoned AU2002212630A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
ITMI2000A002477 2000-11-17
IT2000MI002477A IT1319665B1 (en) 2000-11-17 2000-11-17 CORTICOSTEROID ADDUCTS WITH NATURAL POLYSACCHARIDIC POLYMERS.
PCT/IB2001/002170 WO2002040029A2 (en) 2000-11-17 2001-11-16 Corticosteroids adducts with natural polysaccharide polymers

Publications (1)

Publication Number Publication Date
AU2002212630A1 true AU2002212630A1 (en) 2002-05-27

Family

ID=11446118

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002212630A Abandoned AU2002212630A1 (en) 2000-11-17 2001-11-16 Corticosteroids adducts with natural polysaccharide polymers

Country Status (3)

Country Link
AU (1) AU2002212630A1 (en)
IT (1) IT1319665B1 (en)
WO (1) WO2002040029A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITMI20032054A1 (en) 2003-10-22 2005-04-23 Monteres S R L PROCESS FOR THE PREPARATION OF PHARMACEUTICAL SUSPENSIONS TO BE INHALED.
CN103705470B (en) * 2014-01-06 2015-06-17 南通大学 Methylprednisolone-loading nanoparticles as well as preparation method and application thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8904296D0 (en) * 1989-12-21 1989-12-21 Pharmacia Ab TRANSDERMAL SYSTEM
ATE151991T1 (en) * 1990-12-19 1997-05-15 Advanced Magnetics Inc TARGETING THERAPEUTIC AGENTS BY USING POLYSACCHARIDES
JP2920611B2 (en) * 1995-12-11 1999-07-19 株式会社シーエーシー Topical treatment for dermatitis

Also Published As

Publication number Publication date
WO2002040029A2 (en) 2002-05-23
WO2002040029A3 (en) 2002-10-31
IT1319665B1 (en) 2003-10-23
ITMI20002477A1 (en) 2002-05-17

Similar Documents

Publication Publication Date Title
AU2509700A (en) Polysaccharide fibers
AU2001231447A1 (en) Artificial tree
AU7647000A (en) Increasing the polysaccharide content in plants
AU6009001A (en) Self-lubricating polymers
AU2001262237A1 (en) Reflector
AU2216601A (en) Variable delay generator
AU2001260327A1 (en) Chair
AU6474400A (en) Compressor
AU4095101A (en) Scaled-feedback turbo decoder
AU2001285810A1 (en) High functional polymers
AU5126800A (en) Low delay decoding
AU2001295775A1 (en) Getters
AU3305400A (en) Mains
AU3883800A (en) Hob-bp2h compositions, methods and uses thereof
AU2002212631A1 (en) Adducts of quinolonic agents with natural polysaccharide polymers
AU2001266176A1 (en) Methods
AU2002212630A1 (en) Corticosteroids adducts with natural polysaccharide polymers
AU2001252200A1 (en) Chair
AU5524200A (en) Antibiotic-natural polysaccharide polymer adducts
AU2001218611A1 (en) Stent
AU2001284503A1 (en) Enzyme-mimicking polymers
AU2001250536A1 (en) Methods
AU2002256556A1 (en) Sea-trosy and related methods
AU4308001A (en) Transition metal-cyclopentadienyl-tropane conjugates
AUPQ549100A0 (en) Improvements in cooking appliances